Could the Spark Biomedical and AcuityMD Partnership Be a Game-Changer?
DALLAS, TX—Spark Biomedical develops a topical, minimally invasive medical device for alleviating opioid withdrawal symptoms. AcuityMD has a platform for helping medical device companies accelerate commercial access to their products.
In October 2022, Spark and AcuityMD announceda partnership that could provide a pathway to sobriety to millions suffering from opioid addiction. The FDA-approved Sparrow therapy system represents a drug-free tool for helping treat opioid use disorder. It sends mild electrical impulses to the brain to help alleviate withdrawal symptoms.